EP1796703A4 - Carrier-free composition for the treatment of onychomycosis - Google Patents

Carrier-free composition for the treatment of onychomycosis

Info

Publication number
EP1796703A4
EP1796703A4 EP04789085A EP04789085A EP1796703A4 EP 1796703 A4 EP1796703 A4 EP 1796703A4 EP 04789085 A EP04789085 A EP 04789085A EP 04789085 A EP04789085 A EP 04789085A EP 1796703 A4 EP1796703 A4 EP 1796703A4
Authority
EP
European Patent Office
Prior art keywords
onychomycosis
carrier
treatment
free composition
free
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04789085A
Other languages
German (de)
French (fr)
Other versions
EP1796703A1 (en
Inventor
Nair G Muraleedharan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Michigan State University MSU
Original Assignee
Michigan State University MSU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michigan State University MSU filed Critical Michigan State University MSU
Publication of EP1796703A1 publication Critical patent/EP1796703A1/en
Publication of EP1796703A4 publication Critical patent/EP1796703A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
EP04789085A 2004-09-24 2004-09-24 Carrier-free composition for the treatment of onychomycosis Withdrawn EP1796703A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/031630 WO2006036144A1 (en) 2004-09-24 2004-09-24 Carrier-free composition for the treatment of onychomycosis

Publications (2)

Publication Number Publication Date
EP1796703A1 EP1796703A1 (en) 2007-06-20
EP1796703A4 true EP1796703A4 (en) 2009-07-01

Family

ID=36119190

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04789085A Withdrawn EP1796703A4 (en) 2004-09-24 2004-09-24 Carrier-free composition for the treatment of onychomycosis

Country Status (4)

Country Link
EP (1) EP1796703A4 (en)
JP (1) JP2008514596A (en)
CA (1) CA2581606A1 (en)
WO (1) WO2006036144A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1036661C2 (en) 2009-03-04 2010-09-07 Serrix B V Anti-fungal compounds & compositions.
DE202010012041U1 (en) 2010-08-31 2010-11-18 Sanderstrothmann Gmbh Preparation for nail care
CN103893599A (en) * 2014-04-12 2014-07-02 张军 External traditional Chinese medicine lotion for treating onychomycosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04154719A (en) * 1990-10-19 1992-05-27 Hiroshi Kikuchi Athlete's foot drug
SK163899A3 (en) * 1997-05-30 2000-08-14 Procter & Gamble Disinfecting compositions
JP2000128800A (en) * 1998-10-16 2000-05-09 Hideyo Yamaguchi Prevention of infection of dermatophytosis and/or its treatment and tool and material for treatment
US6344190B1 (en) * 1999-02-08 2002-02-05 Board Of Trustees Of Michigan State University Method and compositions for treatment of fungal nail disease
US6436424B1 (en) * 2000-03-20 2002-08-20 Biosphere Medical, Inc. Injectable and swellable microspheres for dermal augmentation
JP2003073290A (en) * 2001-08-31 2003-03-12 Kao Corp Composition for external preparation

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
RAMSEWAK RUSSEL S ET AL: "In vitro antagonistic activity of monoterpenes and their mixtures against 'toe nail fungus' pathogens.", PHYTOTHERAPY RESEARCH : PTR APR 2003, vol. 17, no. 4, April 2003 (2003-04-01), pages 376 - 379, XP002527754, ISSN: 0951-418X *
ROBERTS D T ET AL: "Guidelines for treatment of onychomycosis.", BRITISH JOURNAL OF DERMATOLOGY, vol. 148, no. 3, March 2003 (2003-03-01), pages 402 - 410, XP002527755, ISSN: 0007-0963 *
See also references of WO2006036144A1 *

Also Published As

Publication number Publication date
JP2008514596A (en) 2008-05-08
WO2006036144A1 (en) 2006-04-06
EP1796703A1 (en) 2007-06-20
AU2004323577A1 (en) 2006-04-06
WO2006036144A8 (en) 2007-06-14
CA2581606A1 (en) 2006-04-06

Similar Documents

Publication Publication Date Title
EP1727530A4 (en) Topical formulations for the treatment of skin conditions
HK1123509A1 (en) Hair treatment compositions
PL1863899T3 (en) Skin treatment compositions
EP1563831A4 (en) External composition for skin
ZA200803523B (en) Hair treatment compositions
ZA200803524B (en) Hair treatment compositions
IL187405A0 (en) Methods and compositions for the treatment of pain
HK1111599A1 (en) Pharmaceutical compositions for the treatment of cellulite
IL186022A0 (en) Dermatological compositions and salts for the treatment of dermatological diseases
HU0500145D0 (en) Composition for the treatment of oral diseases
EP1904088A4 (en) Compositions and methods for the treatment of cancer
IL187792A0 (en) 4-anilino-3-quinolinecarbonitriles for the treatment of cancer
EP1797430A4 (en) Methods and compositions for the diagnosis and treatment of cancer
GB0400802D0 (en) Compounds for the treatment of disease
EP1796703A4 (en) Carrier-free composition for the treatment of onychomycosis
IL185900A0 (en) Compositions and methods for the diagnosis and treatment of tumor
IL178907A0 (en) Use of sulglicotide for the treatment of mucositis
GB0505203D0 (en) Skin composition treatment
ZA200606780B (en) Compounds for the treatment of diseases
ZA200706159B (en) Compositions and methods for the diagnosis and treatment of tumor
GB0313630D0 (en) Compositions for the enhanced treatment of depression
IL185691A0 (en) Novel compounds derived from 5-thioxylose and therapeutic use thereof
AU2003240174A8 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
ZA200710476B (en) Methods and compositions for the treatment of pain
ZA200708279B (en) Dermatological compositions and salts for the treatment of dermatological diseases

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070404

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20090602

17Q First examination report despatched

Effective date: 20090811

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110712